BACKGROUND: Mitral regurgitation (MR) is the second leading cause of valvular heart disease in the United States behind aortic stenosis. The percutaneous repair of the mitral valve (MitraClip, Abbott, Inc.) has been approved in the United States since 2013 as an alternative to traditional mitral valve surgery. However, many questions are left unanswered about when to perform this procedure and whom to perform it on. METHODS: We reviewed major published literature on the MitraClip from 2003-2016 to help guide clinical decision-making. A PubMed search was conducted using the phrase "mitraclip" or "percutaneous mitral valve repair" to identify relevant articles pertaining to the clip as well as surgical valve repair. RESULTS: The clinical trials EVEREST I and EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) demonstrated the safety and efficacy of the MitraClip but did not prove its superiority to surgical repair in the population studied. Numerous subsequent registries have suggested that the success of the MitraClip varies with the patient population studied. The currently enrolling Cardiovascular Outcomes for Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional MR (COAPT) trial hopes to answer some of these questions. CONCLUSION: The MitraClip is a new and exciting technology for percutaneously treating disease processes traditionally managed with surgery. The future of the clip and its patient population is dependent on further studies.
BACKGROUND:Mitral regurgitation (MR) is the second leading cause of valvular heart disease in the United States behind aortic stenosis. The percutaneous repair of the mitral valve (MitraClip, Abbott, Inc.) has been approved in the United States since 2013 as an alternative to traditional mitral valve surgery. However, many questions are left unanswered about when to perform this procedure and whom to perform it on. METHODS: We reviewed major published literature on the MitraClip from 2003-2016 to help guide clinical decision-making. A PubMed search was conducted using the phrase "mitraclip" or "percutaneous mitral valve repair" to identify relevant articles pertaining to the clip as well as surgical valve repair. RESULTS: The clinical trials EVEREST I and EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) demonstrated the safety and efficacy of the MitraClip but did not prove its superiority to surgical repair in the population studied. Numerous subsequent registries have suggested that the success of the MitraClip varies with the patient population studied. The currently enrolling Cardiovascular Outcomes for Assessment of the MitraClip Percutaneous Therapy for Heart FailurePatients with Functional MR (COAPT) trial hopes to answer some of these questions. CONCLUSION: The MitraClip is a new and exciting technology for percutaneously treating disease processes traditionally managed with surgery. The future of the clip and its patient population is dependent on further studies.
Authors: Frederick G St Goar; James I Fann; Jan Komtebedde; Elyse Foster; Mehmet C Oz; Thomas J Fogarty; Ted Feldman; Peter C Block Journal: Circulation Date: 2003-10-06 Impact factor: 29.690
Authors: James I Fann; Frederick G St Goar; Jan Komtebedde; Mehmet C Oz; Peter C Block; Elyse Foster; Jagdish Butany; Ted Feldman; Thomas A Burdon Journal: Circulation Date: 2004-08-09 Impact factor: 29.690
Authors: Ted Feldman; Hal S Wasserman; Howard C Herrmann; William Gray; Peter C Block; Patrick Whitlow; Fred St Goar; Leonardo Rodriguez; Frank Silvestry; Allan Schwartz; Timothy A Sanborn; Jose A Condado; Elyse Foster Journal: J Am Coll Cardiol Date: 2005-10-19 Impact factor: 24.094
Authors: Mariana Mirabel; Bernard Iung; Gabriel Baron; David Messika-Zeitoun; Delphine Détaint; Jean-Louis Vanoverschelde; Eric G Butchart; Philippe Ravaud; Alec Vahanian Journal: Eur Heart J Date: 2007-03-09 Impact factor: 29.983
Authors: Patrick L Whitlow; Ted Feldman; Wes R Pedersen; D Scott Lim; Robert Kipperman; Richard Smalling; Tanvir Bajwa; Howard C Herrmann; John Lasala; James T Maddux; Murat Tuzcu; Samir Kapadia; Alfredo Trento; Robert J Siegel; Elyse Foster; Donald Glower; Laura Mauri; Saibal Kar Journal: J Am Coll Cardiol Date: 2012-01-10 Impact factor: 24.094
Authors: Benjamin H Trichon; G Michael Felker; Linda K Shaw; Christopher H Cabell; Christopher M O'Connor Journal: Am J Cardiol Date: 2003-03-01 Impact factor: 2.778
Authors: Ted Feldman; Saibal Kar; Michael Rinaldi; Peter Fail; James Hermiller; Richard Smalling; Patrick L Whitlow; William Gray; Reginald Low; Howard C Herrmann; Scott Lim; Elyse Foster; Donald Glower Journal: J Am Coll Cardiol Date: 2009-08-18 Impact factor: 24.094
Authors: Laura Mauri; Elyse Foster; Donald D Glower; Patricia Apruzzese; Joseph M Massaro; Howard C Herrmann; James Hermiller; William Gray; Andrew Wang; Wesley R Pedersen; Tanvir Bajwa; John Lasala; Reginald Low; Paul Grayburn; Ted Feldman Journal: J Am Coll Cardiol Date: 2013-05-09 Impact factor: 24.094
Authors: D Scott Lim; Matthew R Reynolds; Ted Feldman; Saibal Kar; Howard C Herrmann; Andrew Wang; Patrick L Whitlow; William A Gray; Paul Grayburn; Michael J Mack; Donald D Glower Journal: J Am Coll Cardiol Date: 2013-10-31 Impact factor: 24.094